GPR40 antagonist (Advinus Therapeutics)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameGPR40 antagonist (Advinus Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFree fatty acid receptor 1 antagonists
TargetsFree fatty acid receptor 1
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEurofins Advinus Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEurofins Advinus Ltd
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksN/A